Sionna Therapeutics(SION),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SION Sionna Therapeutics

Closed Good Friday 04-17 16:00:00 EDT

11.07

+1.07

+10.70%

盘后11.07

+0.000.00%

16:00 EDT

High11.51	Low9.39	Vol186.21K
Open9.68	D1 Closing10.00	Amplitude21.20%
Mkt Cap488.46M	Tradable Cap176.49M	Total Shares44.12M
T/O2.04M	T/O Rate1.17%	Tradable Shares15.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":11.07,"timestamp":1744920000000,"preClose":10,"halted":0,"volume":186207,"hourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.07,"latestTime":"16:00 EDT","volume":2081,"amount":23036.67,"timestamp":1744920007145},"delay":0,"floatShares":15943083,"shares":44124394,"eps":-15.986072,"marketStatus":"Closed Good Friday","change":1.07,"latestTime":"04-17 16:00:00 EDT","open":9.68,"high":11.51,"low":9.39,"amount":2040956.7276,"amplitude":0.212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.986072,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":10,"preHourTrading":{"tag":"盘前","latestPrice":9.67,"preClose":10,"latestTime":"07:02 EDT","volume":538,"amount":4936.619674,"timestamp":1744887734606},"postHourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.07,"latestTime":"16:00 EDT","volume":2081,"amount":23036.67,"timestamp":1744920007145},"volumeRatio":1.3690140965305357},"requestUrl":"/m/hq/s/SION","defaultTab":"news","newsList":[{"id":"2521255434","title":"TD Cowen Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521255434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521255434?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 02:55","pubTimestamp":1742583350,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Sionna Therapeutics, Inc. (SION – Research Report) today. The company’s shares opened today ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-sticks-to-their-buy-rating-for-sionna-therapeutics-inc-sion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","SION","TD"],"gpt_icon":0},{"id":"2520043069","title":"Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2520043069","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520043069?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:18","pubTimestamp":1742469488,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44413626/sionna-therapeutics-q4-eps-3-38-up-from-3-93-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Sionna Therapeutics Q4 EPS $(3.38) Up From $(3.93) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2520374454","title":"Sionna Therapeutics - Qtrly Loss per Share $3.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2520374454","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520374454?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:00","pubTimestamp":1742468402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA9HJBBJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2520437381","title":"Press Release: Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437381?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:00","pubTimestamp":1742468400,"startTime":"0","endTime":"0","summary":"Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline data anticipated in first half of 2025. On track to initiate NBD1 Phase 2a proof-of-concept trial in combination with SOC in CF patients and combination MAD trials of an NBD1 stabilizer with a complementary modulator in healthy volunteers in the second half of 2025, with topline data for both anticipated in mid-2026. Completed upsized IPO with gross proceeds of approximately $219 million, extending runway into 2028","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4093","BK4218","BK4588","BK4213","BK4139","SOC","CF","SION","PK","BK4585","BK4181"],"gpt_icon":0},{"id":"2519346994","title":"Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2519346994","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519346994?lang=en_us&edition=full_marsco","pubTime":"2025-03-16 04:43","pubTimestamp":1742071388,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other top insider purchases last month.How will new tariffs impact the U.S. economy?What’s next on President Trump’s geopolitical agenda?These are some of the concerning questions influencing market conditions.According to J.P. Morgan’s chief global economist, Bruce Kasman, there is about a 40% chance of a U.S. recession and a risk of lasting damage to the country’s reputation as an investment destination, writes Reuters.“Where we stand now is with a heightened concern about the U.S. economy,” Kasman said to reporters in Singapore on Wednesday.Additionally, Goldman Sachs lowered its 2025-end target for the broader market. “The proximate causes of the market decline are the jump in policy uncertainty largely related to tariffs, concerns about the economic growth outlook, and a positioning unwind, especially among hedge funds","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-inc-sion-among-204308018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0034235188.USD","BK4516","IE00BFXG1179.USD","LU2237443895.HKD","LU2237443622.USD","IE0004091025.USD","LU1868836591.USD","BK4585","BK4139","LU1791807156.HKD","LU2237443549.SGD","LU2471134796.USD","LU1868837136.USD","LU2471134523.USD","LU1868837300.USD","LU2237443382.USD","BK4533","BK4093","LU2750360997.AUD","IE0004086264.USD","LU1868836757.USD","LU2750360641.GBP","SION","BK4504","BK4550","LU1868836914.USD","LU1668664300.SGD","LU2471134952.CNY","LU2237443978.SGD","LU0061475181.USD","LU2237443465.HKD","CF","LU2237438978.USD","IE00BSNM7G36.USD","LU0096364046.USD","LU2471134879.HKD","IE00B19Z3B42.SGD","BK4127","BK4552","IE0002270589.USD","LU0106831901.USD","IE00B19Z3581.USD","BK4588"],"gpt_icon":0},{"id":"2517961079","title":"U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961079","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517961079?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 15:53","pubTimestamp":1741161195,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott InternationalMarch 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO0SE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4114","BK4539","MAR","BK4139","CHH","BK4121","LU2463526074.USD","YUM","AZO","BK4560","CHPT","WH","H","LU0965509010.AUD","LU2238339852.HKD","MGA","SNDK","WDC","IE00B894F039.SGD","CRWD","LU2092937221.SGD","LU2360108059.USD","BOX","LU1934455194.USD","ROST","LU2362541513.USD","ACCD","TGT","LU2125910336.SGD","LU2229751404.USD","LU0240877869.USD","ACHC","LU2106854487.HKD","AKYA","LU0965508806.USD","LU2237443978.SGD","WM","RSG","SGRY","BK4185","LU1934455863.HKD","LU1720051017.SGD","BBY","HLT","SION","INGM","LU0106261612.USD","LU0211328371.USD","LU0240878834.USD","PASG"],"gpt_icon":1},{"id":"2517957069","title":"Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517957069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517957069?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 13:59","pubTimestamp":1741154363,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PO093:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2516367153","title":"Sionna Therapeutics initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2516367153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516367153?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 21:36","pubTimestamp":1741095415,"startTime":"0","endTime":"0","summary":"TD Cowen initiated coverage of Sionna Therapeutics (SION) with a Buy rating. Sionna’s pipeline of cystic fibrosis therapies directly target NBD1, w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","BK4127","TD","BK4139","BK4585","BK4207","BK4566","SION"],"gpt_icon":0},{"id":"2516991673","title":"Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2516991673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516991673?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 20:36","pubTimestamp":1741091762,"startTime":"0","endTime":"0","summary":"Guggenheim Initiates Sionna Therapeutics at Buy With $45 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"gpt_icon":0},{"id":"2516529673","title":"Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2516529673","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516529673?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 20:32","pubTimestamp":1741091533,"startTime":"0","endTime":"0","summary":"Stifel Initiates Sionna Therapeutics at Buy With $32 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","SION"],"gpt_icon":0},{"id":"2516735526","title":"TD Cowen Initiates Sionna Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2516735526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516735526?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 20:30","pubTimestamp":1741091429,"startTime":"0","endTime":"0","summary":"TD Cowen Initiates Sionna Therapeutics at Buy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TD","BK4207","SION","BK4127","BK4566","COWN","BK4585","BK4139"],"gpt_icon":0},{"id":"2516678739","title":"Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678739?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 20:28","pubTimestamp":1741091325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2516678805","title":"Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678805?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 19:55","pubTimestamp":1741089335,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are desig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/goldman-sachs-starts-sionna-therapeutics-with-early-stage-biotech-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/goldman-sachs-starts-sionna-therapeutics-with-early-stage-biotech-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868837136.USD","LU0106831901.USD","LU2471134952.CNY","LU2237443895.HKD","LU0061475181.USD","IE0004091025.USD","LU2237443465.HKD","IE0034235188.USD","IE0004086264.USD","BK4504","LU2237443622.USD","BK4585","BK4533","IE00BFXG1179.USD","BK4139","IE00B19Z3B42.SGD","LU2750360641.GBP","LU2237443549.SGD","LU2237438978.USD","SSI","LU2471134879.HKD","LU1791807156.HKD","SION","BK4516","LU1868836757.USD","LU2237443978.SGD","LU1868836591.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0096364046.USD","LU1868836914.USD","LU1868837300.USD","LU2237443382.USD","BK4552","LU2471134796.USD","IE00BSNM7G36.USD","LU2750360997.AUD","BK4127","LU2471134523.USD","LU1668664300.SGD","BK4588","BK4550"],"gpt_icon":0},{"id":"2516264946","title":"Sionna Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2516264946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516264946?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 17:55","pubTimestamp":1741082142,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Sionna Therapeutics (SION) with a Buy rating and $45 price target The firm has a positive view of NBD1 stabilizati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2516623001","title":"Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2516623001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516623001?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 17:26","pubTimestamp":1741080389,"startTime":"0","endTime":"0","summary":"Paul Matteis, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Sionna Therapeutics, Inc. (SION). Paul Matteis has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-nbd1-stabilizers-poised-to-challenge-vertex-in-the-11-billion-cf-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-nbd1-stabilizers-poised-to-challenge-vertex-in-the-11-billion-cf-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4093","LU0058720904.USD","LU1093756168.USD","LU2456880835.USD","LU0757428866.USD","LU0417517546.SGD","LU0889565916.HKD","LU0823416689.USD","LU2324357040.USD","VTNR","LU0061475181.USD","BK4532","IE00B2B36J28.USD","LU1559883803.SGD","LU1035775433.USD","BK4139","LU1093756325.SGD","LU2362541273.HKD","LU2362541513.USD","BK4567","IE00B19Z9Z06.USD","LU0234570918.USD","LU0256863811.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0002270589.USD","CF","IE00B19Z3581.USD","LU1585245621.USD","BK4588","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU1815336091.USD","IE00BJJMRZ35.SGD","LU0566484027.USD","LU2237438978.USD","LU2362540622.SGD","LU1069344957.HKD","IE0009355771.USD","LU2417539215.USD","LU0079474960.USD","SION","IE00BZ9MQY76.HKD","VERX","BK4023","IE00B4R5TH58.HKD","BK4533","LU0320765992.SGD","BK4138","VRTX"],"gpt_icon":0},{"id":"2516462587","title":"Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516462587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516462587?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 17:26","pubTimestamp":1741080371,"startTime":"0","endTime":"0","summary":"Yatin Suneja, an analyst from Guggenheim, has initiated a new Buy rating on Sionna Therapeutics, Inc. (SION). Yatin Suneja has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-innovative-nbd1-stabilizers-and-strategic-synergies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-innovative-nbd1-stabilizers-and-strategic-synergies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2516651996","title":"Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651996","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516651996?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 01:57","pubTimestamp":1741024667,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other stocks with at least $10 million in insider spending recently.Since Donald Trump took office, the stock market has experienced a roller coaster ride. Nonetheless, despite concerns about tariffs, job cuts, policy changes, and geopolitical uncertainties, the broader market has risen by 1.46% year-to-date. Furthermore, equity strategists in a Reuters poll project that the broader market will finish the year 9% higher than its current level.“Many analysts agree with this projection, arguing that the Trump administration’s policies won’t have long-term negative impacts on economic growth or inflation. Furthermore, Trump is often considered the most pro-stock market president in American history.Our research has shown that we can outperform the market by imitating the top stock picks of the best","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-inc-sion-among-175747124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain",".IXIC","MNQmain","TQQQ","BK4585","USAW.SI","TSYW.SI","USJW.SI","BK4139","SQQQ","NVIW.SI","BK4588","BK4093","QLD","QID","CF","SION","PSQ"],"gpt_icon":1},{"id":"2512116891","title":"BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2512116891","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512116891?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 07:03","pubTimestamp":1739919816,"startTime":"0","endTime":"0","summary":"BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10 Feb 18  - Sionna Therapeutics Inc SION.O:ATLAS VENTURE FUND XI L.P REPORTS 6.5% STAKE IN SIONNA THERAPEUTICS AS OF FEB 10 - SEC FILINGSource text: [ID:]Further company coverage: SION.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2512113493","title":"Atlas Venture Fund Xi L.p Reports 6.5% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2512113493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512113493?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 06:33","pubTimestamp":1739918009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"gpt_icon":0},{"id":"2512162940","title":"Andreas Halvorsen's Strategic Acquisition in Sionna Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162940","media":"GuruFocus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512162940?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 21:29","pubTimestamp":1739885357,"startTime":"0","endTime":"0","summary":"On February 10, 2025, Andreas Halvorsen (Trades, Portfolio), a prominent figure in the investment world, made a significant move by acquiring 2,952,754 shares of Sionna Therapeutics Inc (SION, Financi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2701996/andreas-halvorsens-strategic-acquisition-in-sionna-therapeutics-inc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU0320765646.SGD","LU2111349929.HKD","SION","LU1989772840.SGD","BK4581","LU1732800096.USD","LU1720051017.SGD","LU1162221912.USD","LU0158827781.USD","LU0912757837.SGD","LU2133065610.SGD","BK4568","LU1720051108.HKD","LU2357305700.SGD","LU0314104364.USD","LU1074936037.SGD","LU2271345857.HKD","LU1548497426.USD","BK4551","LU1668664300.SGD","LU0267386448.USD","LU0158827948.USD","LU2028103732.USD","BK4585","LU0795875169.SGD","LU0098860793.USD","LU2023251221.USD","BK4534","BNTX","LU0006306889.USD","LU2089284900.SGD","BK4535","LU1989772923.USD","BK4093","LU0795875086.SGD","LU1732799900.SGD","LU2089283258.USD","LU0106261372.USD","IE00BZ1G4Q59.USD","CF","BK4139","LU0971096721.USD","BK4588","BK4516","LU1363072403.SGD","IE00BKVL7J92.USD","BK4127","BK4504","LU0106831901.USD","BK4548"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sionnatx.com","stockEarnings":[{"period":"1week","weight":0.4452},{"period":"1month","weight":-0.2275},{"period":"3month","weight":-0.385},{"period":"ytd","weight":-0.385}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Sionna Therapeutics","nameEN":"Sionna Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sionna Therapeutics(SION),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sionna Therapeutics(SION) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sionna Therapeutics,SION,Sionna Therapeutics股票,Sionna Therapeutics股票老虎,Sionna Therapeutics股票老虎国际,Sionna Therapeutics行情,Sionna Therapeutics股票行情,Sionna Therapeutics股价,Sionna Therapeutics股市,Sionna Therapeutics股票价格,Sionna Therapeutics股票交易,Sionna Therapeutics股票购买,Sionna Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sionna Therapeutics(SION),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sionna Therapeutics(SION) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}